Form 8-K · Current report
News Corp 8-K, filed Jul 28, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000161
Summary
News Corp reported buying back 66,163 Class A common securities on July 27, 2026 for about US$1.81 million under its 2025 Repurchase Program, which authorizes up to US$1 billion in aggregate repurchases of Class A and Class B common stock. It said approximately US$388.7 million worth of Class A and Class B shares have been purchased under the program to date.
Key points
- News Corp is authorized to repurchase up to an aggregate US$1 billion of its Nasdaq-listed Class A and Class B common stock under the 2025 Repurchase Program.
- The daily buy-back notification covered Class A common stock (ASX code NWSAA) and reported 66,163 securities bought back on July 27, 2026 for total consideration of US$1,813,130.85.
- Cumulative purchases under the program to date were approximately US$388,725,038 worth of Class A and Class B shares.
- For the previous day, the highest price paid was US$27.61 and the lowest was US$27.18.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.